$139 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 30 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 6.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| 4945SC | KINDER MORGAN ENERGY PARTNERSlp - public equity | $13,674,000 | -6.5% | 171,290 | 0.0% | 9.86% | -5.7% | |
| EPD | ENTERPRISE PRODUCTS PARTNERS Llp - public equity | $13,106,000 | -1.8% | 214,712 | 0.0% | 9.45% | -0.9% | |
| MMP | MAGELLAN MIDSTREAM PARTNERS LPlp - public equity | $10,339,000 | +3.5% | 183,220 | 0.0% | 7.45% | +4.5% | |
| ETP | ENERGY TRANSFER PARTNERS LPlp - public equity | $9,378,000 | +3.0% | 180,099 | 0.0% | 6.76% | +3.9% | |
| PAA | PLAINS ALL AMERICAN PIPELINE Llp - public equity | $9,073,000 | -5.6% | 172,302 | 0.0% | 6.54% | -4.8% | |
| MWE | MARKWEST ENERGY PARTNERS LPlp - public equity | $7,737,000 | +8.1% | 107,111 | 0.0% | 5.58% | +9.0% | |
| OKS | ONEOK PARTNERS LPlp - public equity | $6,822,000 | +7.0% | 128,689 | 0.0% | 4.92% | +8.0% | |
| BPL | BUCKEYE PARTNERS LPlp - public equity | $6,355,000 | -6.6% | 96,971 | 0.0% | 4.58% | -5.8% | |
| EEP | ENBRIDGE ENERGY PARTNERS LPlp - public equity | $5,868,000 | -0.1% | 192,697 | 0.0% | 4.23% | +0.8% | |
| WPZ | WILLIAMS PARTNERS LPlp - public equity | $5,712,000 | +2.5% | 108,026 | 0.0% | 4.12% | +3.4% | |
| 2108SC | EL PASO PIPELINE PARTNERS LPlp - public equity | $5,596,000 | -3.3% | 132,533 | 0.0% | 4.03% | -2.5% | |
| SXL | SUNOCO LOGISTICS PARTNERS LPlp - public equity | $4,915,000 | +3.9% | 73,964 | 0.0% | 3.54% | +4.8% | |
| NGLS | TARGA RESOURCES PARTNERS LPlp - public equity | $4,727,000 | +2.0% | 91,844 | 0.0% | 3.41% | +2.9% | |
| RGP | REGENCY ENERGY PARTNERS LPlp - public equity | $4,382,000 | +6.0% | 153,227 | 0.0% | 3.16% | +6.9% | |
| GEL | GENESIS ENERGY LPlp - public equity | $3,736,000 | -3.4% | 74,618 | 0.0% | 2.69% | -2.6% | |
| WES | WESTERN GAS PARTNERS LPlp - public equity | $3,467,000 | -7.3% | 57,656 | 0.0% | 2.50% | -6.5% | |
| BWP | BOARDWALK PIPELINE PARTNERS LPlp - public equity | $3,370,000 | +0.6% | 110,961 | 0.0% | 2.43% | +1.5% | |
| L109PS | ACCESS MIDSTREAM PARTNERS L Plp - public equity | $3,125,000 | +1.3% | 64,680 | 0.0% | 2.25% | +2.2% | |
| NS | NUSTAR ENERGY LPlp - public equity | $2,770,000 | -12.1% | 69,064 | 0.0% | 2.00% | -11.4% | |
| APL | ATLAS PIPELINE PARTNERS LPlp - public equity | $2,394,000 | +1.6% | 61,690 | 0.0% | 1.73% | +2.5% | |
| PVR | PVR PARTNERS L Plp - public equity | $2,367,000 | -15.3% | 102,369 | 0.0% | 1.71% | -14.6% | |
| DCP | DCP MIDSTREAM PARTNERS LPlp - public equity | $2,344,000 | -8.2% | 47,194 | 0.0% | 1.69% | -7.4% | |
| SEP | SPECTRA ENERGY PARTNERS LPlp - public equity | $1,894,000 | -4.6% | 43,167 | 0.0% | 1.36% | -3.8% | |
| TCP | TC PIPELINES LPlp - public equity | $1,875,000 | +0.9% | 38,495 | 0.0% | 1.35% | +1.7% | |
| CRZO | CARRIZO OIL & GAS INC | $1,717,000 | +31.7% | 46,041 | 0.0% | 1.24% | +32.8% | |
| TXN | TEXAS INSTRUMENTS INC | $1,289,000 | +15.6% | 32,000 | 0.0% | 0.93% | +16.6% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $595,000 | +9.6% | 250,000 | 0.0% | 0.43% | +10.6% | |
| FULCRUM ANALYTICS INC SER Apfd | $77,000 | 0.0% | 27,143 | 0.0% | 0.06% | +1.8% | ||
| FULCRUM ANALYTICS INC | $3,000 | 0.0% | 11,447 | 0.0% | 0.00% | 0.0% | ||
| INGNQ | INTROGEN THERAPEUTICS INC | $0 | – | 262,998 | 0.0% | 0.00% | – | |
| LPI | Exit | LAREDO PETROLEUM HOLDINGS INC | $0 | – | -18,750 | -100.0% | -0.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-10-29
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.